RMD · Resmed Inc · Insider Trading

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

This transaction was executed in multiple trades at prices ranging from $222.2135 - $227.581. The price reported above reflects the weighted average sale price.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

Represents date options first become exercisable. Options vest 1/3 per year

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

This transaction was executed in multiple trades at prices ranging from $220.680 - $225.390. The price reported above reflects the weighted average sale price.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

Represents date options first become exercisable. Options vest 1/3 per year.

The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.

Represents performance-based restricted stock units granted on June 1, 2026. The RSUs were earned on August 14, 2026, when the compensation and leadership development committee certified that the applicable performance metrics were met. RSUs vest 1/3 each year on the anniversary of the grant.

Represents performance-based restricted stock units granted on November 20, 2025. The shares were earned on August 14, 2026, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.

Represents performance-based restricted stock units granted on November 20, 2025. The RSUs were earned on August 14, 2026, when the compensation and leadership development committee certified that the applicable performance metrics were met. RSUs vest 1/3 each year on the anniversary of the grant.

Represents performance-based restricted stock units granted on November 20, 2025. The RSUs were earned on August 14, 2026, when the compensation and leadership development committee certified that the applicable performance metrics were met. RSUs vest 1/3 each year on the anniversary of the grant.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

This transaction was executed in multiple trades at prices ranging from $202.410 - $204.160. The price reported above reflects the weighted average sale price.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

Represents date options first become exercisable. Options vest 1/3 per year.

The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

Represents date options first become exercisable. Options vest 1/3 per year.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

This transaction was executed in multiple trades at prices ranging from $216.772 - $219.700. The price reported above reflects the weighted average sale price.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

This transaction was executed in multiple trades at prices ranging from $192.605 - $194.715. The price reported above reflects the weighted average sale price.

Includes 32.671 shares of Resmed stock purchased on April 30, 2026 through the Resmed Employee Stock Purchase Plan.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 06/01/2023.

Includes 66.0288 shares of Resmed stock purchased on April 30, 2026 through the Resmed Employee Stock Purchase Plan.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

Represents date options first become exercisable. Options vest 1/3 per year.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

This transaction was executed in multiple trades at prices ranging from $206.45 - $210.47. The price reported above reflects the weighted average sale price.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

Represents date options first become exercisable. Options vest 1/3 per year.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

This transaction was executed in multiple trades at prices ranging from $222.5643 - $227.96. The price reported above reflects the weighted average sale price.

The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

Represents date options first become exercisable. Options vest 1/3 per year.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

This transaction was executed in multiple trades at prices ranging from $246.83 - $253.09. The price reported above reflects the weighted average sale price.

The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

Represents date options first become exercisable. Options vest 1/3 per year.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

This transaction was executed in multiple trades at prices ranging from $270.25 - $276.35. The price reported above reflects the weighted average sale price.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted February 28, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

Represents date options first become exercisable. Options vest 1/3 per year.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

This transaction was executed in multiple trades at prices ranging from $246.801 - $249.969. The price reported above reflects the weighted average sale price.

The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted February 28, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

This transaction was executed in multiple trades at prices ranging from $249.63 - $255.775. The price reported above reflects the weighted average sale price.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

Represents date options first become exercisable. Options vest 1/3 per year.